How to Triage a Portfolio Into Go / Hold / Kill Decisions

What the meeting is really about

Portfolio triage often presents itself as a scientific review. In practice it is a capital-allocation exercise.

That changes what counts as a strong output. The organization needs more than a view of each asset in isolation. It needs a defensible answer to which programs deserve more resources now, which should wait for a defined trigger, and which should stop consuming scarce money and time.

Why these meetings fail so predictably

Portfolio reviews usually fail in the same way. Each team argues for its own program on bespoke terms. Criteria shift as the discussion moves. Hold becomes the politically safe default. The deck gets revised but the allocation barely changes.

That is delay disguised as triage.

Step 1: set the criteria before discussing assets

The hardest and most useful move is to agree on the frame first.

Typical criteria include:

• strength of scientific rationale
• maturity of evidence
• development feasibility and timing
• IP and competitive pressure
• strategic fit with company thesis
• capital intensity
• value of the next inflection point

Once those criteria are fixed, it becomes much harder to hide weak tradeoffs behind storytelling.

Step 2: normalize the evidence frame

Every asset can receive a different depth of work, but each should face the same top-level questions.

For each program, the team should be able to say:

• what is true scientifically?
• what has changed recently?
• what is operationally difficult about this path?
• what does success buy the company?
• what else is competing for the same dollars?

That final question is the one portfolio decks routinely underplay.

Step 3: define the buckets rigorously

Go

The evidence, timing, and strategic fit justify more resources now.

Investigate

The signal is potentially good enough to matter, but the evidence is still too thin or too conflicted to force a true Go or Kill.

Hold

The program may still matter, but additional capital should wait until a clearly defined condition changes.

Kill

The program no longer clears the bar relative to better uses of capital. The decision should preserve learnings and release resources.

Many leadership teams talk as if the choice is only Go, Hold, or Kill. In practice, a serious workflow usually needs an Investigate bucket as well. Otherwise the organization ends up pretending to have conviction where it really has incomplete evidence.

The emotional difficulty of Kill is exactly why the definition should be explicit, and the operational danger of premature Go is why Investigate should exist.

Step 4: tie every bucket to action

A triage output needs a next move for each decision.

• Go: what gets funded, expanded, or accelerated?
• Investigate: which evidence gap has to close, by when, and who owns it?
• Hold: what event reopens the case?
• Kill: what stops, and what knowledge is preserved?

That is how the review becomes an operating mechanism rather than a recurring ritual.

The review usually fails before the scoring model does

Portfolio processes often get blamed on weak scoring models. More often the real problem is organizational drift.

The review begins with one stated objective and ends with a different one. A strategic fit discussion quietly becomes a defense of sunk cost. Management asks for a capital-allocation view but reacts as if the exercise were a referendum on scientific merit. The result is a process that looks analytical while remaining politically evasive.

That is why a strong triage workflow needs explicit definitions, evidence floors, and confidence rules. Otherwise the organization will use sophistication to avoid making the decision it asked for.

How ARiDA helps

This is one of the places where grounding the workflow really matters. ARiDA's base portfolio skill is a defined portfolio quick screen that produces Go, Investigate, Hold, and Kill verdicts with confidence gating. The Investigate bucket is deliberate: the workflow keeps thin evidence from masquerading as conviction. Portfolio Optimization extends that base with GE-McKinsey, BCG, stage-gate, three-horizons, efficient-frontier, and real-options work. Portfolio Strategic Prioritization reconciles those frameworks into a single board-grade dossier.

Operationally, that means the workflow can stage pipeline verification, competitive density, IP coverage, quick rNPV, probability-of-success estimates, and the scoring matrix before the recommendation is written. The database specialist, patent specialist, web research specialist, valuation specialist, and coding specialist all contribute different evidence to the same frame. The final decision can then be revisited quarter after quarter without pretending the prior reasoning never existed.

The allocation test

The heart of portfolio triage is whether a program deserves scarce capital relative to what else the company could do.

A strong workflow forces that comparison into the open and leaves a record the organization can revisit honestly.